Thermo Fisher Scientific (TMO) balance sheet

NYSE · Healthcare · Medical - Diagnostics & Research · 125,000 employees · CEO Marc N. Casper

Price: $697.00 -1.72%
Market cap: $258B
Enterprise value: $294B
Last report: Q3 '26 filed 2026-10-30
Next report: 2027-02-04 EPS est. $7.13

At the end of Q3 '26 Thermo Fisher Scientific (TMO) held $6.06B in cash and short-term investments against $41.4B of debt incl. leases. Total assets $114B, total liabilities $59.5B, shareholders' equity $54.8B.

Balance sheet

Balance sheet	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
Assets
Cash & equivalents	$8.08B	$5.51B	$7.08B	$4.65B	$4.02B	$4.13B	$4.58B	$1.98B	$9.85B	$3.25B	$4.06B	$5.46B
Short-term investments	$0	$1.75B	$1.75B	$2B	$1.56B	$1.81B	$1.81B	$1.56B	$253M	$2M	$0	$600M
Receivables	$9.66B	$9.35B	$9.43B	$9.8B	$9.63B	$9.82B	$10B	$10.5B	$10.6B	$10.9B	$9.45B	$9.63B
Inventory	$5.09B	$5.13B	$5.2B	$5.43B	$4.98B	$5.22B	$5.56B	$5.75B	$5.43B	$5.5B	$5.63B	$5.64B
Other current assets	$1.76B	$1.9B	$2.03B	$1.91B	$1.95B	$2.39B	$2.6B	$2.47B	$2.61B	$2.68B	$4.22B	$4.29B
Current assets	$24.6B	$23.6B	$25.5B	$23.8B	$22.1B	$23.4B	$24.6B	$22.3B	$28.7B	$22.3B	$23.4B	$25.6B
Property, plant & equipment (net)	$11B	$9.32B	$9.28B	$9.41B	$10.8B	$9.33B	$9.64B	$10.2B	$10.6B	$10.7B	$10.8B	$10.6B
Long-term investments	$59M	$233M	$492M	$106M	$560M	$0	$0	$0	$0	$0	$0	$0
Goodwill	$44B	$43.8B	$43.8B	$46.7B	$45.9B	$46.5B	$47.2B	$49.3B	$49.4B	$55.2B	$54.8B	$54.3B
Intangible assets	$16.7B	$16B	$15.5B	$16.3B	$15.5B	$15.3B	$15.1B	$16.2B	$15.8B	$19.1B	$18.6B	$18.1B
Other non-current assets	$2.38B	$4.01B	$3.88B	$4.08B	$2.44B	$4.52B	$4.62B	$5.02B	$5.87B	$5.97B	$5.62B	$5.7B
Non-current assets	$74.1B	$73.5B	$73B	$76.6B	$75.2B	$75.7B	$76.6B	$80.7B	$81.6B	$91B	$89.8B	$88.6B
Total assets	$98.7B	$97.1B	$98.5B	$100B	$97.3B	$99B	$101B	$103B	$110B	$113B	$113B	$114B
Liabilities
Accounts payable	$2.87B	$2.56B	$2.55B	$2.61B	$3.08B	$3.05B	$2.98B	$3.12B	$3.62B	$3.34B	$3.27B	$0
Accrued expenses	$1.6B	$1.31B	$1.5B	$1.82B	$1.99B	$4.44B	$4.72B	$5.09B	$5.32B	$5.26B	$5.52B	$0
Short-term debt	$3.87B	$4.45B	$5.12B	$4.12B	$2.48B	$2.82B	$2.21B	$3.82B	$3.53B	$3.09B	$3.37B	$2.26B
Deferred revenue	$2.69B	$2.63B	$2.59B	$2.66B	$2.85B	$2.87B	$2.81B	$2.85B	$2.71B	$2.93B	$2.92B	$0
Other current liabilities	$2.98B	$2.99B	$3.02B	$3.39B	$2.94B	-$1M	$1M	$0	$0	$0	-$2M	$11.9B
Current liabilities	$14B	$13.9B	$14.8B	$14.6B	$13.3B	$13.2B	$12.7B	$14.9B	$15.2B	$14.6B	$15.1B	$14.2B
Long-term debt	$31.3B	$31.2B	$30.3B	$31.2B	$29.1B	$31.4B	$33B	$31.9B	$35.9B	$40.1B	$39.2B	$39.1B
Lease obligations (non-current)	$1.24B	$0	$0	$0	$1.24B	$0	$0	$0	$0	$0	$0	$0
Deferred revenue (non-current)	$1.5B	$1.43B	$1.46B	$1.43B	$1.14B	$0	$0	$0	$0	$0	$0	$0
Deferred tax liabilities	$1.92B	$1.81B	$1.52B	$1.12B	$1.27B	$1.04B	$624M	$842M	$1.49B	$2.11B	$1.58B	$1.47B
Other non-current liabilities	$1.9B	$3.14B	$2.94B	$2.92B	$1.61B	$3.97B	$4.27B	$4.28B	$4.27B	$4.42B	$4.54B	$4.72B
Non-current liabilities	$37.9B	$37.5B	$36.2B	$36.7B	$34.3B	$36.4B	$37.9B	$37B	$41.6B	$46.6B	$45.3B	$45.3B
Total liabilities	$51.9B	$51.5B	$51B	$51.3B	$47.7B	$49.6B	$50.6B	$51.9B	$56.8B	$61.2B	$60.5B	$59.5B
Equity
Common stock & paid-in capital	$442M	$443M	$443M	$444M	$444M	$444M	$444M	$445M	$445M	$445M	$446M	$447M
Retained earnings	$47.4B	$48.5B	$49.9B	$51.4B	$53.1B	$54.4B	$55.9B	$57.4B	$59.2B	$60.6B	$62.2B	$63.7B
Accumulated other comprehensive income	-$3.22B	-$2.76B	-$2.41B	-$2.48B	-$2.7B	-$2.34B	-$2.8B	-$2.8B	-$2.45B	-$2.5B	-$2.46B	-$2.26B
Shareholders' equity	$46.7B	$45.5B	$47.4B	$49B	$49.6B	$49.4B	$50.5B	$51B	$53.4B	$51.9B	$52.7B	$54.8B
Debt
Total debt (incl. leases)	$36.4B	$35.6B	$35.4B	$35.3B	$32.8B	$34.2B	$35.2B	$35.7B	$39.4B	$43.2B	$42.5B	$41.4B
Net debt (debt - cash)	$28.3B	$30.1B	$28.3B	$30.7B	$28.8B	$30.1B	$30.7B	$33.7B	$29.5B	$39.9B	$38.5B	$35.9B

Balance sheet	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Assets
Cash & equivalents	$786M	$1.34B	$2.1B	$2.4B	$10.3B	$4.48B	$8.52B	$8.08B	$4.02B	$9.85B
Short-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$1.56B	$253M
Receivables	$3.05B	$3.88B	$4.6B	$4.95B	$6.47B	$8.95B	$9.43B	$9.66B	$9.63B	$10.6B
Inventory	$2.21B	$2.97B	$3.01B	$3.37B	$4.03B	$5.05B	$5.63B	$5.09B	$4.98B	$5.43B
Other current assets	$973M	$1.24B	$922M	$1.17B	$1.13B	$1.64B	$1.64B	$1.76B	$1.95B	$2.61B
Current assets	$7.02B	$9.42B	$10.6B	$11.9B	$22B	$20.1B	$25.2B	$24.6B	$22.1B	$28.7B
Property, plant & equipment (net)	$2.58B	$4.05B	$4.17B	$5.45B	$6.69B	$9.86B	$10.9B	$11B	$10.8B	$10.6B
Long-term investments	$37M	$34M	$53M	$35M	$65M	$73M	$155M	$59M	$560M	$0
Goodwill	$21.3B	$25.3B	$25.3B	$25.7B	$26B	$41.9B	$41.2B	$44B	$45.9B	$49.4B
Intangible assets	$14B	$16.7B	$15B	$14B	$12.7B	$20.1B	$17.5B	$16.7B	$15.5B	$15.8B
Other non-current assets	$975M	$1.19B	$1.06B	$1.28B	$1.57B	$3B	$2.22B	$2.38B	$2.44B	$5.87B
Non-current assets	$38.9B	$47.2B	$45.6B	$46.5B	$47.1B	$75B	$71.9B	$74.1B	$75.2B	$81.6B
Total assets	$45.9B	$56.7B	$56.2B	$58.4B	$69.1B	$95.1B	$97.2B	$98.7B	$97.3B	$110B
Liabilities
Accounts payable	$926M	$1.43B	$1.62B	$1.92B	$2.18B	$2.87B	$3.38B	$2.87B	$3.08B	$3.62B
Accrued expenses	$709M	$918M	$982M	$1.01B	$1.92B	$2.43B	$2.1B	$1.6B	$1.99B	$5.32B
Short-term debt	$1.26B	$2.14B	$1.27B	$843M	$2.81B	$2.8B	$5.85B	$3.87B	$2.48B	$3.53B
Taxes payable	$165M	$432M	$0	$0	$0	$0	$0	$0	$0	$0
Deferred revenue	$486M	$719M	$809M	$916M	$1.27B	$2.66B	$2.6B	$2.69B	$2.85B	$2.71B
Other current liabilities	$1.32B	$1.85B	$1.47B	$1.51B	$2.13B	$2.68B	$3.08B	$2.98B	$2.94B	$0
Current liabilities	$4.87B	$7.05B	$6.15B	$6.2B	$10.3B	$13.4B	$17B	$14B	$13.3B	$15.2B
Long-term debt	$15.5B	$18.9B	$17.7B	$17.1B	$19.1B	$32.1B	$28.9B	$31.3B	$29.1B	$35.9B
Lease obligations (non-current)	$10.3M	$10M	$9M	$571M	$626M	$1.39B	$1.31B	$1.24B	$1.24B	$0
Deferred revenue (non-current)	$0	$0	$355M	$594M	$763M	$1.24B	$1.18B	$1.5B	$1.14B	$0
Deferred tax liabilities	$2.56B	$2.77B	$2.27B	$2.19B	$1.79B	$3.84B	$2.85B	$1.92B	$1.27B	$1.49B
Other non-current liabilities	$1.57B	$2.57B	$2.16B	$2.08B	$1.94B	$2.1B	$1.75B	$1.9B	$1.61B	$4.27B
Non-current liabilities	$19.5B	$24.2B	$22.5B	$22.5B	$24.2B	$40.7B	$36B	$37.9B	$34.3B	$41.6B
Total liabilities	$24.4B	$31.3B	$28.6B	$28.7B	$34.5B	$54.1B	$53B	$51.9B	$47.7B	$56.8B
Equity
Common stock & paid-in capital	$415M	$428M	$432M	$434M	$437M	$439M	$441M	$442M	$444M	$445M
Retained earnings	$13.9B	$15.9B	$18.7B	$22.1B	$28.1B	$35.4B	$41.9B	$47.4B	$53.1B	$59.2B
Accumulated other comprehensive income	-$2.64B	-$2B	-$2.5B	-$2.68B	-$2.81B	-$2.33B	-$3.1B	-$3.22B	-$2.7B	-$2.45B
Shareholders' equity	$21.5B	$25.4B	$27.6B	$29.7B	$34.5B	$40.8B	$44B	$46.7B	$49.6B	$53.4B
Debt
Total debt (incl. leases)	$16.6B	$21B	$19B	$18.5B	$22.5B	$36.3B	$36.1B	$36.4B	$32.8B	$39.4B
Net debt (debt - cash)	$15.8B	$19.6B	$16.9B	$16.1B	$12.2B	$31.9B	$27.5B	$28.3B	$28.8B	$29.5B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Income statementRevenue, costs, operating income, net income and EPSOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-26, 10-Q 2026-06-27, 10-Q 2026-03-28, 10-K 2025-12-31, 10-Q 2025-09-27, 10-Q 2025-06-28, 10-Q 2025-03-29, 10-K 2024-12-31, 10-Q 2024-09-28

Data as of 2026-11-01